Company intelligence / Profile preview

Biomol

Hamburg, Hamburg, Germany

Ownership: Private
Employees: ~18
Development stage: Other

Overview

Biomol is a leading European distributor of research reagents, antibodies, biochemicals, diagnostic kits, and associated life science research consumables. It does not develop therapeutic drugs but enables biomedical research through sourcing and supplying high-quality reagents, with an extensive global portfolio and technical support team[1][2][3][6].

Modalities: AntibodyEnzymeBioactive lipidProteinSmall moleculeAssay kitMicroarrayPCR kit
Industry: Chemicals & Materials

Partnerships

Cayman Chemical Company (past/acquirer)Specialized manufacturers (over 60 suppliers)

Beyond the preview

Go deeper on Biomol.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biomol.

Explore the full profile